Back to today’s briefing

Story perspectives

Breakthrough Alzheimer’s Drugs Boost Independence by Months

2/21/2025

42 5

Summary

Story summary

Alzheimer's drugs lecanemab and donanemab can significantly enhance patients' quality of life, allowing them to live independently for an additional 10 and 8 months, respectively. This groundbreaking research from Washington University in St. Louis underscores the critical need for early intervention, equipping patients with vital knowledge about potential benefits, risks, and side effects like brain swelling.

1 of 1

Story summary

Alzheimer's drugs lecanemab and donanemab can significantly enhance patients' quality of life, allowing them to live independently for an additional 10 and 8 months, respectively. This groundbreaking research from Washington University in St. Louis underscores the critical need for early intervention, equipping patients with vital knowledge about potential benefits, risks, and side effects like brain swelling.